ArticleTranslational lung cancer research2023

Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?

Lara Kujtan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.